Funding

Funding

Icosavax Stock Skyrockets 200% on First Day of Trading for Newly Public Seattle Biotech Company

• Posted onAugust 2, 2021 Last Updated: August 2, 2021
• By: Kaitlyn Campitiello

Funding

Absci Shares Spike 30% in IPO Debut, Valuing Washington State Biotech Company at Nearly $2B

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Campitiello

Funding

Eliem Therapeutics Files for IPO as Another Seattle-Area Biotech Firm Set to Go Public

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Campitiello

Funding

Ultrapotent, Nanoparticle COVID-19 Vaccine with University of Washington Roots Gets $173M for Human Trials

• Posted onJune 7, 2021 Last Updated: June 7, 2021
• By: Kaitlyn Campitiello

Funding

Seattle’s Eliem Therapeutics Raises $60M to Advance Drug Pipeline

• Posted onJune 2, 2021 Last Updated: June 2, 2021
• By: Kaitlyn Campitiello

Funding

Sana Biotechnology Sets Sights on Growth After $587.5M IPO

• Posted onMay 24, 2021 Last Updated: May 24, 2021
• By: Kaitlyn Campitiello

Funding

Medical Device Startup Nanodropper Raises $1.4M for Eye Drop Bottle Adapter

• Posted onApril 26, 2021 Last Updated: April 26, 2021
• By: Kaitlyn Campitiello

Funding

Seattle Biotech OncoResponse Raises $40.6M to Create Antibody-Based Treatments for Cancer

• Posted onApril 12, 2021 Last Updated: April 12, 2021
• By: Kaitlyn Campitiello

Funding

Seattle Biotech Startup Outpace Bio Raises $30M to Fight Cancer with Custom-Designed Proteins

• Posted onApril 12, 2021 Last Updated: April 12, 2021
• By: Kaitlyn Campitiello

Funding

UW Spinout Raises $100M for Vaccine Development

• Posted onApril 12, 2021 Last Updated: April 12, 2021
• By: Kaitlyn Campitiello